Literature DB >> 14614313

Histone methyltransferases in tumor suppression.

Keun-Cheol Kim1, Shi Huang.   

Abstract

It is well established that human cancer can be caused by mutations in the molecular pathways that control cell proliferation, differentiation, and survival. Familial cancer syndromes are associated with mutations in tumor susceptibility genes. However, sporadic common cancers are primarily linked to environmental factors that often lack any obvious mutagens. This raises the question whether mutation is necessary for environmental carcinogens to cause cancer. Histone methyltransferases function to control mitotic inheritance of cell fate and gene expression patterns and can turn environmental effects into heritable changes in cell phenotypes. The discovery of tumor suppressor function for these enzymes has important implications for an epigenetic pathway of cancer.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14614313     DOI: 10.4161/cbt.2.5.629

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  15 in total

Review 1.  Chemical and biochemical approaches in the study of histone methylation and demethylation.

Authors:  Keqin Kathy Li; Cheng Luo; Dongxia Wang; Hualiang Jiang; Y George Zheng
Journal:  Med Res Rev       Date:  2012-07       Impact factor: 12.944

2.  DNA methylation and carcinogenesis of PRDM5 in cervical cancer.

Authors:  Hai-Yan Cheng; Xiu-Wei Chen; Li Cheng; Yun-Duo Liu; Ge Lou
Journal:  J Cancer Res Clin Oncol       Date:  2010-03-06       Impact factor: 4.553

3.  Construction of PR domain eukaryotic expression vector and its inhibitory effect on esophageal cancer cells.

Authors:  Yuan Chen; Peng Zhang; Yuanguo Wang; Shangwen Dong; Yimei Liu
Journal:  Chin J Cancer Res       Date:  2013-10       Impact factor: 5.087

4.  The role of a newly identified SET domain-containing protein, SETD3, in oncogenesis.

Authors:  Zhangguo Chen; Catherine T Yan; Yali Dou; Sawanee S Viboolsittiseri; Jing H Wang
Journal:  Haematologica       Date:  2012-10-12       Impact factor: 9.941

5.  A histone methyltransferase is required for maximal response to female sex hormones.

Authors:  Tobias Carling; Keun-Cheol Kim; Xiao-Hong Yang; Jian Gu; Xiao-Kun Zhang; Shi Huang
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

6.  Anticancer activity of the PR domain of tumor suppressor RIZ1.

Authors:  Wanpeng Sun; Ling Qiao; Qiang Liu; Lifeng Chen; Binbing Ling; Ramaswami Sammynaiken; Jian Yang
Journal:  Int J Med Sci       Date:  2011-02-21       Impact factor: 3.738

7.  Functional mechanisms for human tumor suppressors.

Authors:  Wanpeng Sun; Jian Yang
Journal:  J Cancer       Date:  2010-09-15       Impact factor: 4.207

8.  Prdm14 initiates lymphoblastic leukemia after expanding a population of cells resembling common lymphoid progenitors.

Authors:  E J Dettman; S J Simko; B Ayanga; B L Carofino; J F Margolin; H C Morse; M J Justice
Journal:  Oncogene       Date:  2011-02-21       Impact factor: 9.867

9.  The epigenetic modifier PRDM5 functions as a tumor suppressor through modulating WNT/β-catenin signaling and is frequently silenced in multiple tumors.

Authors:  Xing-sheng Shu; Hua Geng; Lili Li; Jianming Ying; Chunhong Ma; Yajun Wang; Fan Fong Poon; Xian Wang; Ying Ying; Winnie Yeo; Gopesh Srivastava; Sai Wah Tsao; Jun Yu; Joseph J Y Sung; Shi Huang; Anthony T C Chan; Qian Tao
Journal:  PLoS One       Date:  2011-11-08       Impact factor: 3.240

10.  The SET-domain protein SUVR5 mediates H3K9me2 deposition and silencing at stimulus response genes in a DNA methylation-independent manner.

Authors:  Elena Caro; Hume Stroud; Maxim V C Greenberg; Yana V Bernatavichute; Suhua Feng; Martin Groth; Ajay A Vashisht; James Wohlschlegel; Steve E Jacobsen
Journal:  PLoS Genet       Date:  2012-10-11       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.